APO Research
Talk to an analyst

APO RESEARCH · REPORT

Drug Coated Stent System

Compare research editions
View pricing & licenses

Selected research

Industry Research

Drug Coated Stent System Industry Research Report 2026

24 December 2025132 pages

Choose your research edition.

Industry ResearchDrug Coated Stent System Industry Research Report 2026132 pages · $2,950 USDIndustry Growth & TrendsGlobal Drug Coated Stent System Industry Growth and Trends Forecast to 2032113 pages · $3,450 USDMarket StructureGlobal Drug Coated Stent System Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032190 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Drug Coated Stent System Market Outlook and Growth Opportunities 2026206 pages · $4,250 USDMarket Analysis & ForecastGlobal Drug Coated Stent System Market Analysis and Forecast 2026-2032200 pages · $4,950 USD

Market perspective

The global Drug Coated Stent System market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.

The North America market for Drug Coated Stent System is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.

The Europe market for Drug Coated Stent System is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.

Read the full market overview

The Asia Pacific market for Drug Coated Stent System is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.

Leading global manufacturers of Drug Coated Stent System include MicroPort Scientific Corporation, Shanghai Bio-heart Biological Technology, Shandong Huaan Biotechnology, SINOMED, Lepu Medical Technology, Blue Sail Medical, Kinhely Bio-Tech, JW Medical Systems and USM Healthcare, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report quantifies the global Drug Coated Stent System market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.

It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).

The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.

Key Companies & Market Share Insights

This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.

Drug Coated Stent System Market by Company

MicroPort Scientific Corporation

Shanghai Bio-heart Biological Technology

Shandong Huaan Biotechnology

SINOMED

Lepu Medical Technology

Blue Sail Medical

Kinhely Bio-Tech

JW Medical Systems

USM Healthcare

QualiMe

P+F Products + Features GmbH

MicroPort

Medtronic

Concept Medical Inc

Cardionovum

Boston Scientific

Biotronik

Abbott

Drug Coated Stent System Segment by Type

Rapamycin Coated Stent

Ivimox Coated Bracket

Paclitaxel Coated Stent

Zothamos Coated Bracket

Drug Coated Stent System Segment by Application

Hospital

Clinic

Others

Drug Coated Stent System Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Drug Coated Stent System market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Drug Coated Stent System and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Drug Coated Stent System.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;

Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 3: Detailed analysis of Drug Coated Stent System manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.

Chapter 5: Production/output, value of Drug Coated Stent System by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.

Chapter 6: Consumption of Drug Coated Stent System in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.

Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 11: The main points and conclusions of the report.

More report detail

Tables and figures
List of Tables Table 1. Secondary Sources Table 2. Primary Sources Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Drug Coated Stent System Volume and Revenue Market Size and CAGR of Manufacturers (2021 Versus 2025) Table 6. Global Drug Coated Stent System Sales (K Units) of Manufacturers (2021-2026) Table 7. Global Drug Coated Stent System Sales Market Share by Manufacturers (2021-2026) Table 8. Global Drug Coated Stent System Revenue of Manufacturers (2021-2026) Table 9. Global Drug Coated Stent System Revenue Share by Manufacturers (2021-2026) Table 10. Global Market Drug Coated Stent System Average Price (US$/Unit) of Manufacturers (2021-2026) Table 11. Global Drug Coated Stent System Industry Ranking, 2024 VS 2025 VS 2026 Table 12. Global Manufacturers of Drug Coated Stent System, Manufacturing Sites & Headquarters Table 13. Global Manufacturers of Drug Coated Stent System, Product Type & Application Table 14. Global Drug Coated Stent System Manufacturers Established Date Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 16. Global Drug Coated Stent System by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans) Table 18. MicroPort Scientific Corporation Company Information Table 19. MicroPort Scientific Corporation Business Overview Table 20. MicroPort Scientific Corporation Drug Coated Stent System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 21. MicroPort Scientific Corporation Drug Coated Stent System Product Portfolio Table 22. MicroPort Scientific Corporation Recent Developments Table 23. Shanghai Bio-heart Biological Technology Company Information Table 24. Shanghai Bio-heart Biological Technology Business Overview Table 25. Shanghai Bio-heart Biological Technology Drug Coated Stent System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 26. Shanghai Bio-heart Biological Technology Drug Coated Stent System Product Portfolio Table 27. Shanghai Bio-heart Biological Technology Recent Developments Table 28. Shandong Huaan Biotechnology Company Information Table 29. Shandong Huaan Biotechnology Business Overview Table 30. Shandong Huaan Biotechnology Drug Coated Stent System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 31. Shandong Huaan Biotechnology Drug Coated Stent System Product Portfolio Table 32. Shandong Huaan Biotechnology Recent Developments Table 33. SINOMED Company Information Table 34. SINOMED Business Overview Table 35. SINOMED Drug Coated Stent System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 36. SINOMED Drug Coated Stent System Product Portfolio Table 37. SINOMED Recent Developments Table 38. Lepu Medical Technology Company Information Table 39. Lepu Medical Technology Business Overview Table 40. Lepu Medical Technology Drug Coated Stent System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 41. Lepu Medical Technology Drug Coated Stent System Product Portfolio Table 42. Lepu Medical Technology Recent Developments Table 43. Blue Sail Medical Company Information Table 44. Blue Sail Medical Business Overview Table 45. Blue Sail Medical Drug Coated Stent System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 46. Blue Sail Medical Drug Coated Stent System Product Portfolio Table 47. Blue Sail Medical Recent Developments Table 48. Kinhely Bio-Tech Company Information Table 49. Kinhely Bio-Tech Business Overview Table 50. Kinhely Bio-Tech Drug Coated Stent System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 51. Kinhely Bio-Tech Drug Coated Stent System Product Portfolio Table 52. Kinhely Bio-Tech Recent Developments Table 53. JW Medical Systems Company Information Table 54. JW Medical Systems Business Overview Table 55. JW Medical Systems Drug Coated Stent System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 56. JW Medical Systems Drug Coated Stent System Product Portfolio Table 57. JW Medical Systems Recent Developments Table 58. USM Healthcare Company Information Table 59. USM Healthcare Business Overview Table 60. USM Healthcare Drug Coated Stent System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 61. USM Healthcare Drug Coated Stent System Product Portfolio Table 62. USM Healthcare Recent Developments Table 63. QualiMe Company Information Table 64. QualiMe Business Overview Table 65. QualiMe Drug Coated Stent System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 66. QualiMe Drug Coated Stent System Product Portfolio Table 67. QualiMe Recent Developments Table 68. P+F Products + Features GmbH Company Information Table 69. P+F Products + Features GmbH Business Overview Table 70. P+F Products + Features GmbH Drug Coated Stent System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 71. P+F Products + Features GmbH Drug Coated Stent System Product Portfolio Table 72. P+F Products + Features GmbH Recent Developments Table 73. MicroPort Company Information Table 74. MicroPort Business Overview Table 75. MicroPort Drug Coated Stent System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 76. MicroPort Drug Coated Stent System Product Portfolio Table 77. MicroPort Recent Developments Table 78. Medtronic Company Information Table 79. Medtronic Business Overview Table 80. Medtronic Drug Coated Stent System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 81. Medtronic Drug Coated Stent System Product Portfolio Table 82. Medtronic Recent Developments Table 83. Concept Medical Inc Company Information Table 84. Concept Medical Inc Business Overview Table 85. Concept Medical Inc Drug Coated Stent System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 86. Concept Medical Inc Drug Coated Stent System Product Portfolio Table 87. Concept Medical Inc Recent Developments Table 88. Cardionovum Company Information Table 89. Cardionovum Business Overview Table 90. Cardionovum Drug Coated Stent System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 91. Cardionovum Drug Coated Stent System Product Portfolio Table 92. Cardionovum Recent Developments Table 93. Boston Scientific Company Information Table 94. Boston Scientific Business Overview Table 95. Boston Scientific Drug Coated Stent System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 96. Boston Scientific Drug Coated Stent System Product Portfolio Table 97. Boston Scientific Recent Developments Table 98. Biotronik Company Information Table 99. Biotronik Business Overview Table 100. Biotronik Drug Coated Stent System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 101. Biotronik Drug Coated Stent System Product Portfolio Table 102. Biotronik Recent Developments Table 103. Abbott Company Information Table 104. Abbott Business Overview Table 105. Abbott Drug Coated Stent System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 106. Abbott Drug Coated Stent System Product Portfolio Table 107. Abbott Recent Developments Table 108. Global Drug Coated Stent System Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Table 109. Global Drug Coated Stent System Sales by Region (2021-2026) & (K Units) Table 110. Global Drug Coated Stent System Sales Market Share by Region (2021-2026) Table 111. Global Drug Coated Stent System Sales by Region (2027-2032) & (K Units) Table 112. Global Drug Coated Stent System Sales Market Share by Region (2027-2032) Table 113. Global Drug Coated Stent System Revenue by Region (2021-2026) & (US$ Million) Table 114. Global Drug Coated Stent System Revenue Market Share by Region (2021-2026) Table 115. Global Drug Coated Stent System Revenue by Region (2027-2032) & (US$ Million) Table 116. Global Drug Coated Stent System Revenue Market Share by Region (2027-2032) Table 117. North America Drug Coated Stent System Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 118. North America Drug Coated Stent System Sales by Country (2021-2026) & (K Units) Table 119. North America Drug Coated Stent System Sales by Country (2027-2032) & (K Units) Table 120. North America Drug Coated Stent System Revenue by Country (2021-2026) & (US$ Million) Table 121. North America Drug Coated Stent System Revenue by Country (2027-2032) & (US$ Million) Table 122. Europe Drug Coated Stent System Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 123. Europe Drug Coated Stent System Sales by Country (2021-2026) & (K Units) Table 124. Europe Drug Coated Stent System Sales by Country (2027-2032) & (K Units) Table 125. Europe Drug Coated Stent System Revenue by Country (2021-2026) & (US$ Million) Table 126. Europe Drug Coated Stent System Revenue by Country (2027-2032) & (US$ Million) Table 127. Asia Pacific Drug Coated Stent System Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 128. Asia Pacific Drug Coated Stent System Sales by Country (2021-2026) & (K Units) Table 129. Asia Pacific Drug Coated Stent System Sales by Country (2027-2032) & (K Units) Table 130. Asia Pacific Drug Coated Stent System Revenue by Country (2021-2026) & (US$ Million) Table 131. Asia Pacific Drug Coated Stent System Revenue by Country (2027-2032) & (US$ Million) Table 132. South America Drug Coated Stent System Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 133. South America Drug Coated Stent System Sales by Country (2021-2026) & (K Units) Table 134. South America Drug Coated Stent System Sales by Country (2027-2032) & (K Units) Table 135. South America Drug Coated Stent System Revenue by Country (2021-2026) & (US$ Million) Table 136. South America Drug Coated Stent System Revenue by Country (2027-2032) & (US$ Million) Table 137. Middle East and Africa Drug Coated Stent System Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 138. Middle East and Africa Drug Coated Stent System Sales by Country (2021-2026) & (K Units) Table 139. Middle East and Africa Drug Coated Stent System Sales by Country (2027-2032) & (K Units) Table 140. Middle East and Africa Drug Coated Stent System Revenue by Country (2021-2026) & (US$ Million) Table 141. Middle East and Africa Drug Coated Stent System Revenue by Country (2027-2032) & (US$ Million) Table 142. Global Drug Coated Stent System Sales by Type (2021-2026) & (K Units) Table 143. Global Drug Coated Stent System Sales by Type (2027-2032) & (K Units) Table 144. Global Drug Coated Stent System Sales Market Share by Type (2021-2026) Table 145. Global Drug Coated Stent System Sales Market Share by Type (2027-2032) Table 146. Global Drug Coated Stent System Revenue by Type (2021-2026) & (US$ Million) Table 147. Global Drug Coated Stent System Revenue by Type (2027-2032) & (US$ Million) Table 148. Global Drug Coated Stent System Revenue Market Share by Type (2021-2026) Table 149. Global Drug Coated Stent System Revenue Market Share by Type (2027-2032) Table 150. Global Drug Coated Stent System Price by Type (2021-2026) & (US$/Unit) Table 151. Global Drug Coated Stent System Price by Type (2027-2032) & (US$/Unit) Table 152. Global Drug Coated Stent System Sales by Application (2021-2026) & (K Units) Table 153. Global Drug Coated Stent System Sales by Application (2027-2032) & (K Units) Table 154. Global Drug Coated Stent System Sales Market Share by Application (2021-2026) Table 155. Global Drug Coated Stent System Sales Market Share by Application (2027-2032) Table 156. Global Drug Coated Stent System Revenue by Application (2021-2026) & (US$ Million) Table 157. Global Drug Coated Stent System Revenue by Application (2027-2032) & (US$ Million) Table 158. Global Drug Coated Stent System Revenue Market Share by Application (2021-2026) Table 159. Global Drug Coated Stent System Revenue Market Share by Application (2027-2032) Table 160. Global Drug Coated Stent System Price by Application (2021-2026) & (US$/Unit) Table 161. Global Drug Coated Stent System Price by Application (2027-2032) & (US$/Unit) Table 162. Key Raw Materials Table 163. Raw Materials Key Suppliers Table 164. Drug Coated Stent System Distributors List Table 165. Drug Coated Stent System Customers List Table 166. Drug Coated Stent System Industry Trends Table 167. Drug Coated Stent System Industry Drivers Table 168. Drug Coated Stent System Industry Restraints Table 169. Authors List of This Report List of Figures Figure 1. Research Methodology Figure 2. Research Process Figure 3. Key Executives Interviewed Figure 4. Drug Coated Stent System Product Image Figure 5. Global Drug Coated Stent System Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 6. Global Drug Coated Stent System Market Size (2021-2032) & (US$ Million) Figure 7. Global Drug Coated Stent System Sales (2021-2032) & (K Units) Figure 8. Global Drug Coated Stent System Average Price (US$/Unit) & (2021-2032) Figure 9. Rapamycin Coated Stent Product Image Figure 10. Ivimox Coated Bracket Product Image Figure 11. Paclitaxel Coated Stent Product Image Figure 12. Zothamos Coated Bracket Product Image Figure 13. Hospital Product Image Figure 14. Clinic Product Image Figure 15. Others Product Image Figure 16. Global Drug Coated Stent System Revenue Share by Manufacturers in 2025 Figure 17. Global Manufacturers of Drug Coated Stent System, Manufacturing Sites & Headquarters Figure 18. Global Top 5 and 10 Drug Coated Stent System Players Market Share by Revenue in 2025 Figure 19. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 20. Global Drug Coated Stent System Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Figure 21. Global Drug Coated Stent System Sales by Region in 2025 Figure 22. Global Drug Coated Stent System Revenue by Region in 2025 Figure 23. North America Drug Coated Stent System Market Size by Country in 2025 Figure 24. North America Drug Coated Stent System Sales Market Share by Country (2021-2032) Figure 25. North America Drug Coated Stent System Revenue Market Share by Country (2021-2032) Figure 26. United States Drug Coated Stent System Revenue Growth Rate (2021-2032) & (US$ Million) Figure 27. Canada Drug Coated Stent System Revenue Growth Rate (2021-2032) & (US$ Million) Figure 28. Mexico Drug Coated Stent System Revenue Growth Rate (2021-2032) & (US$ Million) Figure 29. Europe Drug Coated Stent System Market Size by Country in 2025 Figure 30. Europe Drug Coated Stent System Sales Market Share by Country (2021-2032) Figure 31. Europe Drug Coated Stent System Revenue Market Share by Country (2021-2032) Figure 32. Germany Drug Coated Stent System Revenue Growth Rate (2021-2032) & (US$ Million) Figure 33. France Drug Coated Stent System Revenue Growth Rate (2021-2032) & (US$ Million) Figure 34. U.K. Drug Coated Stent System Revenue Growth Rate (2021-2032) & (US$ Million) Figure 35. Italy Drug Coated Stent System Revenue Growth Rate (2021-2032) & (US$ Million) Figure 36. Russia Drug Coated Stent System Revenue Growth Rate (2021-2032) & (US$ Million) Figure 37. Spain Drug Coated Stent System Revenue Growth Rate (2021-2032) & (US$ Million) Figure 38. Netherlands Drug Coated Stent System Revenue Growth Rate (2021-2032) & (US$ Million) Figure 39. Switzerland Drug Coated Stent System Revenue Growth Rate (2021-2032) & (US$ Million) Figure 40. Sweden Drug Coated Stent System Revenue Growth Rate (2021-2032) & (US$ Million) Figure 41. Poland Drug Coated Stent System Revenue Growth Rate (2021-2032) & (US$ Million) Figure 42. Asia Pacific Drug Coated Stent System Market Size by Country in 2025 Figure 43. Asia Pacific Drug Coated Stent System Sales Market Share by Country (2021-2032) Figure 44. Asia Pacific Drug Coated Stent System Revenue Market Share by Country (2021-2032) Figure 45. China Drug Coated Stent System Revenue Growth Rate (2021-2032) & (US$ Million) Figure 46. Japan Drug Coated Stent System Revenue Growth Rate (2021-2032) & (US$ Million) Figure 47. South Korea Drug Coated Stent System Revenue Growth Rate (2021-2032) & (US$ Million) Figure 48. India Drug Coated Stent System Revenue Growth Rate (2021-2032) & (US$ Million) Figure 49. Australia Drug Coated Stent System Revenue Growth Rate (2021-2032) & (US$ Million) Figure 50. Taiwan Drug Coated Stent System Revenue Growth Rate (2021-2032) & (US$ Million) Figure 51. Southeast Asia Drug Coated Stent System Revenue Growth Rate (2021-2032) & (US$ Million) Figure 52. Southeast Asia Drug Coated Stent System Revenue Growth Rate (2021-2032) & (US$ Million) Figure 53. South America Drug Coated Stent System Market Size by Country in 2025 Figure 54. South America Drug Coated Stent System Sales Market Share by Country (2021-2032) Figure 55. South America Drug Coated Stent System Revenue Market Share by Country (2021-2032) Figure 56. Brazil Drug Coated Stent System Revenue Growth Rate (2021-2032) & (US$ Million) Figure 57. Argentina Drug Coated Stent System Revenue Growth Rate (2021-2032) & (US$ Million) Figure 58. Chile Drug Coated Stent System Revenue Growth Rate (2021-2032) & (US$ Million) Figure 59. Middle East and Africa Drug Coated Stent System Market Size by Country in 2025 Figure 60. Middle East and Africa Drug Coated Stent System Sales Market Share by Country (2021-2032) Figure 61. Middle East and Africa Drug Coated Stent System Revenue Market Share by Country (2021-2032) Figure 62. Egypt Drug Coated Stent System Revenue Growth Rate (2021-2032) & (US$ Million) Figure 63. South Africa Drug Coated Stent System Revenue Growth Rate (2021-2032) & (US$ Million) Figure 64. Israel Drug Coated Stent System Revenue Growth Rate (2021-2032) & (US$ Million) Figure 65. Türkiye Drug Coated Stent System Revenue Growth Rate (2021-2032) & (US$ Million) Figure 66. GCC Countries Drug Coated Stent System Revenue Growth Rate (2021-2032) & (US$ Million) Figure 67. Global Drug Coated Stent System Sales Market Share by Type (2021-2032) Figure 68. Global Drug Coated Stent System Revenue Market Share by Type (2021-2032) Figure 69. Global Drug Coated Stent System Price (US$/Unit) by Type (2021-2032) Figure 70. Global Drug Coated Stent System Sales Market Share by Application (2021-2032) Figure 71. Global Drug Coated Stent System Revenue Market Share by Application (2021-2032) Figure 72. Global Drug Coated Stent System Price (US$/Unit) by Application (2021-2032) Figure 73. Drug Coated Stent System Value Chain Figure 74. Drug Coated Stent System Production Mode & Process Figure 75. Direct Comparison with Distribution Share Figure 76. Distributors Profiles Figure 77. Drug Coated Stent System Industry Opportunities and Challenges

Scope & coverage.

Types
  • Rapamycin Coated Stent
  • Ivimox Coated Bracket
  • Paclitaxel Coated Stent
  • Zothamos Coated Bracket
Applications
  • Hospital
  • Clinic
  • Others
Companies covered
  • MicroPort Scientific Corporation
  • Shanghai Bio-heart Biological Technology
  • Shandong Huaan Biotechnology
  • SINOMED
  • Lepu Medical Technology
  • Blue Sail Medical
  • Kinhely Bio-Tech
  • JW Medical Systems
  • USM Healthcare
  • QualiMe
  • P+F Products + Features GmbH
  • MicroPort
  • Medtronic
  • Concept Medical Inc
  • Cardionovum
  • Boston Scientific
  • Biotronik
  • Abbott

Inside the report.

1 Preface
  1. 1.1 Scope of Report
  2. 1.2 Reasons for Doing This Study
  3. 1.3 Research Methodology
  4. 1.4 Research Process
  5. 1.5 Data Source
  6. 1.5.1 Secondary Sources
  7. 1.5.2 Primary Sources
2 Market Overview
  1. 2.1 Product Definition
  2. 2.2 Global Market Growth Prospects
  3. 2.2.1 Global Drug Coated Stent System Market Size (2021-2032)
  4. 2.2.2 Global Drug Coated Stent System Sales (2021-2032)
  5. 2.2.3 Global Drug Coated Stent System Market Average Price (2021-2032)
  6. 2.3 Drug Coated Stent System by Type
  7. 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
  8. 2.3.2 Rapamycin Coated Stent
  9. 2.3.3 Ivimox Coated Bracket
  10. 2.3.4 Paclitaxel Coated Stent
  11. 2.3.5 Zothamos Coated Bracket
  12. 2.4 Drug Coated Stent System by Application
  13. 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
  14. 2.4.2 Hospital
  15. 2.4.3 Clinic
  16. 2.4.4 Others
3 Market Competitive Landscape by Manufacturers
  1. 3.1 Global Drug Coated Stent System Market Competitive Situation by Manufacturers (2021 Versus 2025)
  2. 3.2 Global Drug Coated Stent System Sales (K Units) of Manufacturers (2021-2026)
  3. 3.3 Global Drug Coated Stent System Revenue of Manufacturers (2021-2026)
  4. 3.4 Global Drug Coated Stent System Average Price by Manufacturers (2021-2026)
  5. 3.5 Global Drug Coated Stent System Industry Ranking, 2024 VS 2025 VS 2026
  6. 3.6 Global Manufacturers of Drug Coated Stent System, Manufacturing Sites & Headquarters
  7. 3.7 Global Manufacturers of Drug Coated Stent System, Product Type & Application
  8. 3.8 Global Manufacturers of Drug Coated Stent System, Established Date
  9. 3.9 Global Drug Coated Stent System Market CR5 and HHI
  10. 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
  1. 4.1 MicroPort Scientific Corporation
  2. 4.1.1 MicroPort Scientific Corporation Company Information
  3. 4.1.2 MicroPort Scientific Corporation Business Overview
  4. 4.1.3 MicroPort Scientific Corporation Drug Coated Stent System Sales, Revenue and Gross Margin (2021-2026)
  5. 4.1.4 MicroPort Scientific Corporation Drug Coated Stent System Product Portfolio
  6. 4.1.5 MicroPort Scientific Corporation Recent Developments
  7. 4.2 Shanghai Bio-heart Biological Technology
  8. 4.2.1 Shanghai Bio-heart Biological Technology Company Information
  9. 4.2.2 Shanghai Bio-heart Biological Technology Business Overview
  10. 4.2.3 Shanghai Bio-heart Biological Technology Drug Coated Stent System Sales, Revenue and Gross Margin (2021-2026)
  11. 4.2.4 Shanghai Bio-heart Biological Technology Drug Coated Stent System Product Portfolio
  12. 4.2.5 Shanghai Bio-heart Biological Technology Recent Developments
  13. 4.3 Shandong Huaan Biotechnology
  14. 4.3.1 Shandong Huaan Biotechnology Company Information
  15. 4.3.2 Shandong Huaan Biotechnology Business Overview
  16. 4.3.3 Shandong Huaan Biotechnology Drug Coated Stent System Sales, Revenue and Gross Margin (2021-2026)
  17. 4.3.4 Shandong Huaan Biotechnology Drug Coated Stent System Product Portfolio
  18. 4.3.5 Shandong Huaan Biotechnology Recent Developments
  19. 4.4 SINOMED
  20. 4.4.1 SINOMED Company Information
  21. 4.4.2 SINOMED Business Overview
  22. 4.4.3 SINOMED Drug Coated Stent System Sales, Revenue and Gross Margin (2021-2026)
  23. 4.4.4 SINOMED Drug Coated Stent System Product Portfolio
  24. 4.4.5 SINOMED Recent Developments
  25. 4.5 Lepu Medical Technology
  26. 4.5.1 Lepu Medical Technology Company Information
  27. 4.5.2 Lepu Medical Technology Business Overview
  28. 4.5.3 Lepu Medical Technology Drug Coated Stent System Sales, Revenue and Gross Margin (2021-2026)
  29. 4.5.4 Lepu Medical Technology Drug Coated Stent System Product Portfolio
  30. 4.5.5 Lepu Medical Technology Recent Developments
  31. 4.6 Blue Sail Medical
  32. 4.6.1 Blue Sail Medical Company Information
  33. 4.6.2 Blue Sail Medical Business Overview
  34. 4.6.3 Blue Sail Medical Drug Coated Stent System Sales, Revenue and Gross Margin (2021-2026)
  35. 4.6.4 Blue Sail Medical Drug Coated Stent System Product Portfolio
  36. 4.6.5 Blue Sail Medical Recent Developments
  37. 4.7 Kinhely Bio-Tech
  38. 4.7.1 Kinhely Bio-Tech Company Information
  39. 4.7.2 Kinhely Bio-Tech Business Overview
  40. 4.7.3 Kinhely Bio-Tech Drug Coated Stent System Sales, Revenue and Gross Margin (2021-2026)
  41. 4.7.4 Kinhely Bio-Tech Drug Coated Stent System Product Portfolio
  42. 4.7.5 Kinhely Bio-Tech Recent Developments
  43. 4.8 JW Medical Systems
  44. 4.8.1 JW Medical Systems Company Information
  45. 4.8.2 JW Medical Systems Business Overview
  46. 4.8.3 JW Medical Systems Drug Coated Stent System Sales, Revenue and Gross Margin (2021-2026)
  47. 4.8.4 JW Medical Systems Drug Coated Stent System Product Portfolio
  48. 4.8.5 JW Medical Systems Recent Developments
  49. 4.9 USM Healthcare
  50. 4.9.1 USM Healthcare Company Information
  51. 4.9.2 USM Healthcare Business Overview
  52. 4.9.3 USM Healthcare Drug Coated Stent System Sales, Revenue and Gross Margin (2021-2026)
  53. 4.9.4 USM Healthcare Drug Coated Stent System Product Portfolio
  54. 4.9.5 USM Healthcare Recent Developments
  55. 4.10 QualiMe
  56. 4.10.1 QualiMe Company Information
  57. 4.10.2 QualiMe Business Overview
  58. 4.10.3 QualiMe Drug Coated Stent System Sales, Revenue and Gross Margin (2021-2026)
  59. 4.10.4 QualiMe Drug Coated Stent System Product Portfolio
  60. 4.10.5 QualiMe Recent Developments
  61. 4.11 P+F Products + Features GmbH
  62. 4.11.1 P+F Products + Features GmbH Company Information
  63. 4.11.2 P+F Products + Features GmbH Business Overview
  64. 4.11.3 P+F Products + Features GmbH Drug Coated Stent System Sales, Revenue and Gross Margin (2021-2026)
  65. 4.11.4 P+F Products + Features GmbH Drug Coated Stent System Product Portfolio
  66. 4.11.5 P+F Products + Features GmbH Recent Developments
  67. 4.12 MicroPort
  68. 4.12.1 MicroPort Company Information
  69. 4.12.2 MicroPort Business Overview
  70. 4.12.3 MicroPort Drug Coated Stent System Sales, Revenue and Gross Margin (2021-2026)
  71. 4.12.4 MicroPort Drug Coated Stent System Product Portfolio
  72. 4.12.5 MicroPort Recent Developments
  73. 4.13 Medtronic
  74. 4.13.1 Medtronic Company Information
  75. 4.13.2 Medtronic Business Overview
  76. 4.13.3 Medtronic Drug Coated Stent System Sales, Revenue and Gross Margin (2021-2026)
  77. 4.13.4 Medtronic Drug Coated Stent System Product Portfolio
  78. 4.13.5 Medtronic Recent Developments
  79. 4.14 Concept Medical Inc
  80. 4.14.1 Concept Medical Inc Company Information
  81. 4.14.2 Concept Medical Inc Business Overview
  82. 4.14.3 Concept Medical Inc Drug Coated Stent System Sales, Revenue and Gross Margin (2021-2026)
  83. 4.14.4 Concept Medical Inc Drug Coated Stent System Product Portfolio
  84. 4.14.5 Concept Medical Inc Recent Developments
  85. 4.15 Cardionovum
  86. 4.15.1 Cardionovum Company Information
  87. 4.15.2 Cardionovum Business Overview
  88. 4.15.3 Cardionovum Drug Coated Stent System Sales, Revenue and Gross Margin (2021-2026)
  89. 4.15.4 Cardionovum Drug Coated Stent System Product Portfolio
  90. 4.15.5 Cardionovum Recent Developments
  91. 4.16 Boston Scientific
  92. 4.16.1 Boston Scientific Company Information
  93. 4.16.2 Boston Scientific Business Overview
  94. 4.16.3 Boston Scientific Drug Coated Stent System Sales, Revenue and Gross Margin (2021-2026)
  95. 4.16.4 Boston Scientific Drug Coated Stent System Product Portfolio
  96. 4.16.5 Boston Scientific Recent Developments
  97. 4.17 Biotronik
  98. 4.17.1 Biotronik Company Information
  99. 4.17.2 Biotronik Business Overview
  100. 4.17.3 Biotronik Drug Coated Stent System Sales, Revenue and Gross Margin (2021-2026)
  101. 4.17.4 Biotronik Drug Coated Stent System Product Portfolio
  102. 4.17.5 Biotronik Recent Developments
  103. 4.18 Abbott
  104. 4.18.1 Abbott Company Information
  105. 4.18.2 Abbott Business Overview
  106. 4.18.3 Abbott Drug Coated Stent System Sales, Revenue and Gross Margin (2021-2026)
  107. 4.18.4 Abbott Drug Coated Stent System Product Portfolio
  108. 4.18.5 Abbott Recent Developments
5 Global Drug Coated Stent System Market Scenario by Region
  1. 5.1 Global Drug Coated Stent System Market Size by Region: 2021 VS 2025 VS 2032
  2. 5.2 Global Drug Coated Stent System Sales by Region: 2021-2032
  3. 5.2.1 Global Drug Coated Stent System Sales by Region: 2021-2026
  4. 5.2.2 Global Drug Coated Stent System Sales by Region: 2027-2032
  5. 5.3 Global Drug Coated Stent System Revenue by Region: 2021-2032
  6. 5.3.1 Global Drug Coated Stent System Revenue by Region: 2021-2026
  7. 5.3.2 Global Drug Coated Stent System Revenue by Region: 2027-2032
  8. 5.4 North America Drug Coated Stent System Market Facts & Figures by Country
  9. 5.4.1 North America Drug Coated Stent System Market Size by Country: 2021 VS 2025 VS 2032
  10. 5.4.2 North America Drug Coated Stent System Sales by Country (2021-2032)
  11. 5.4.3 North America Drug Coated Stent System Revenue by Country (2021-2032)
  12. 5.4.4 United States
  13. 5.4.5 Canada
  14. 5.4.6 Mexico
  15. 5.5 Europe Drug Coated Stent System Market Facts & Figures by Country
  16. 5.5.1 Europe Drug Coated Stent System Market Size by Country: 2021 VS 2025 VS 2032
  17. 5.5.2 Europe Drug Coated Stent System Sales by Country (2021-2032)
  18. 5.5.3 Europe Drug Coated Stent System Revenue by Country (2021-2032)
  19. 5.5.4 Germany
  20. 5.5.5 France
  21. 5.5.6 U.K.
  22. 5.5.7 Italy
  23. 5.5.8 Russia
  24. 5.5.9 Spain
  25. 5.5.10 Netherlands
  26. 5.5.11 Switzerland
  27. 5.5.12 Sweden
  28. 5.5.13 Poland
  29. 5.6 Asia Pacific Drug Coated Stent System Market Facts & Figures by Country
  30. 5.6.1 Asia Pacific Drug Coated Stent System Market Size by Country: 2021 VS 2025 VS 2032
  31. 5.6.2 Asia Pacific Drug Coated Stent System Sales by Country (2021-2032)
  32. 5.6.3 Asia Pacific Drug Coated Stent System Revenue by Country (2021-2032)
  33. 5.6.4 China
  34. 5.6.5 Japan
  35. 5.6.6 South Korea
  36. 5.6.7 India
  37. 5.6.8 Australia
  38. 5.6.9 Taiwan
  39. 5.6.10 Southeast Asia
  40. 5.7 South America Drug Coated Stent System Market Facts & Figures by Country
  41. 5.7.1 South America Drug Coated Stent System Market Size by Country: 2021 VS 2025 VS 2032
  42. 5.7.2 South America Drug Coated Stent System Sales by Country (2021-2032)
  43. 5.7.3 South America Drug Coated Stent System Revenue by Country (2021-2032)
  44. 5.7.4 Brazil
  45. 5.7.5 Argentina
  46. 5.7.6 Chile
  47. 5.8 Middle East and Africa Drug Coated Stent System Market Facts & Figures by Country
  48. 5.8.1 Middle East and Africa Drug Coated Stent System Market Size by Country: 2021 VS 2025 VS 2032
  49. 5.8.2 Middle East and Africa Drug Coated Stent System Sales by Country (2021-2032)
  50. 5.8.3 Middle East and Africa Drug Coated Stent System Revenue by Country (2021-2032)
  51. 5.8.4 Egypt
  52. 5.8.5 South Africa
  53. 5.8.6 Israel
  54. 5.8.7 Türkiye
  55. 5.8.8 GCC Countries
6 Segment by Type
  1. 6.1 Global Drug Coated Stent System Sales by Type (2021-2032)
  2. 6.1.1 Global Drug Coated Stent System Sales by Type (2021-2032) & (K Units)
  3. 6.1.2 Global Drug Coated Stent System Sales Market Share by Type (2021-2032)
  4. 6.2 Global Drug Coated Stent System Revenue by Type (2021-2032)
  5. 6.2.1 Global Drug Coated Stent System Sales by Type (2021-2032) & (US$ Million)
  6. 6.2.2 Global Drug Coated Stent System Revenue Market Share by Type (2021-2032)
  7. 6.3 Global Drug Coated Stent System Price by Type (2021-2032)
7 Segment by Application
  1. 7.1 Global Drug Coated Stent System Sales by Application (2021-2032)
  2. 7.1.1 Global Drug Coated Stent System Sales by Application (2021-2032) & (K Units)
  3. 7.1.2 Global Drug Coated Stent System Sales Market Share by Application (2021-2032)
  4. 7.2 Global Drug Coated Stent System Revenue by Application (2021-2032)
  5. 7.2.1 Global Drug Coated Stent System Sales by Application (2021-2032) & (US$ Million)
  6. 7.2.2 Global Drug Coated Stent System Revenue Market Share by Application (2021-2032)
  7. 7.3 Global Drug Coated Stent System Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
  1. 8.1 Drug Coated Stent System Value Chain Analysis
  2. 8.1.1 Drug Coated Stent System Key Raw Materials
  3. 8.1.2 Raw Materials Key Suppliers
  4. 8.1.3 Drug Coated Stent System Production Mode & Process
  5. 8.2 Drug Coated Stent System Sales Channels Analysis
  6. 8.2.1 Direct Comparison with Distribution Share
  7. 8.2.2 Drug Coated Stent System Distributors
  8. 8.2.3 Drug Coated Stent System Customers
9 Global Drug Coated Stent System Analyzing Market Dynamics
  1. 9.1 Drug Coated Stent System Industry Trends
  2. 9.2 Drug Coated Stent System Industry Drivers
  3. 9.3 Drug Coated Stent System Industry Opportunities and Challenges
  4. 9.4 Drug Coated Stent System Industry Restraints
10 Report Conclusion
    11 Disclaimer

      GET THE RESEARCH

      Choose your license.

      Choose who needs access.
      All options are for this report and research series.

      Compare access permissions.

      Single User License
      One named user. Individual access.
      Multi User License
      Up to 5 users in the same department.
      Enterprise License
      Organization-wide access within the agreed license.

      Access applies to the purchased edition. Later editions are separate purchases.

      License options
      $2,950USD
      Buy now

      PDF by email within 3–5 working days after payment confirmation.

      Talk to an analyst
      APO Research
      Talk to an analyst